Education
About Us
Working with TipRanks
Follow Us
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
Total Valuation
Krebs Biochemicals & Industries Ltd. has a market cap or net worth of ₹1.70B. The enterprise value is ₹3.69B.
Market Cap₹1.70B
Enterprise Value₹3.69B
Share Statistics
Krebs Biochemicals & Industries Ltd. has 21,560,587 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,560,587
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Krebs Biochemicals & Industries Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -12.01%.
Return on Equity (ROE)0.17
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-12.01%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee―
Profits Per Employee―
Employee Count―
Asset Turnover0.28
Inventory Turnover5.98
Valuation Ratios
The current PE Ratio of Krebs Biochemicals & Industries Ltd. is -7.05. Krebs Biochemicals & Industries Ltd.’s PEG ratio is 0.35.
PE Ratio-7.05
PS Ratio0.00
PB Ratio-1.17
Price to Fair Value-1.17
Price to FCF-27.68
Price to Operating Cash Flow60.36
PEG Ratio0.35
Income Statement
In the last 12 months, Krebs Biochemicals & Industries Ltd. had revenue of 504.21M and earned -197.28M in profits. Earnings per share was -9.15.
Revenue504.21M
Gross Profit-108.75M
Operating Income-151.96M
Pretax Income-197.28M
Net Income-197.28M
EBITDA-82.73M
Earnings Per Share (EPS)-9.15
Cash Flow
In the last 12 months, operating cash flow was 68.83M and capital expenditures 0.00, giving a free cash flow of 68.83M billion.
Operating Cash Flow68.83M
Free Cash Flow68.83M
Free Cash Flow per Share3.19
Dividends & Yields
Krebs Biochemicals & Industries Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change2.89%
50-Day Moving Average77.81
200-Day Moving Average87.71
Relative Strength Index (RSI)45.04
Average Volume (3m)5.00K
Important Dates
Krebs Biochemicals & Industries Ltd. upcoming earnings date is May 26, 2025, TBA Not Confirmed.
Last Earnings DateFeb 4, 2025
Next Earnings DateMay 26, 2025
Ex-Dividend Date―
Financial Position
Krebs Biochemicals & Industries Ltd. as a current ratio of 0.28, with Debt / Equity ratio of -157.18%
Current Ratio0.28
Quick Ratio0.12
Debt to Market Cap1.39
Net Debt to EBITDA-28.83
Interest Coverage Ratio-3.24
Taxes
In the past 12 months, Krebs Biochemicals & Industries Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Krebs Biochemicals & Industries Ltd. EV to EBITDA ratio is -45.64, with an EV/FCF ratio of -75.17.
EV to Sales7.49
EV to EBITDA-45.64
EV to Free Cash Flow-75.17
EV to Operating Cash Flow163.89
Balance Sheet
Krebs Biochemicals & Industries Ltd. has ₹1.37M in cash and marketable securities with ₹1.93B in debt, giving a net cash position of -₹1.37M billion.
Cash & Marketable Securities₹1.37M
Total Debt₹1.93B
Net Cash-₹1.37M
Net Cash Per Share-₹0.06
Tangible Book Value Per Share-₹56.45
Margins
Gross margin is 72.70%, with operating margin of -30.14%, and net profit margin of -39.13%.
Gross Margin72.70%
Operating Margin-30.14%
Pretax Margin-39.13%
Net Profit Margin-39.13%
EBITDA Margin-16.41%
EBIT Margin-29.83%
Analyst Forecast
The average price target for Krebs Biochemicals & Industries Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―